|
1. |
Editorial Note |
|
Neuroepidemiology,
Volume 3,
Issue 2-3,
1984,
Page 57-57
F. Clifford Rose,
Preview
|
PDF (68KB)
|
|
ISSN:0251-5350
DOI:10.1159/000110842
出版商:S. Karger AG
年代:1984
数据来源: Karger
|
2. |
Epidemiology of Multiple Sclerosis |
|
Neuroepidemiology,
Volume 3,
Issue 2-3,
1984,
Page 58-73
Geoffrey Dean,
Preview
|
PDF (1563KB)
|
|
ISSN:0251-5350
DOI:10.1159/000110843
出版商:S. Karger AG
年代:1984
数据来源: Karger
|
3. |
The Age-Specific Prevalence Ratio of Familial Multiple Sclerosis |
|
Neuroepidemiology,
Volume 3,
Issue 2-3,
1984,
Page 74-81
J. Wikström,
E. Kinnunen,
J. Porras,
Preview
|
PDF (810KB)
|
|
摘要:
The epidemiology of multiple sclerosis (MS) in Finland has been under continuous investigation since 1964. A small rural area in the western part of the country was selected for detailed familial analysis. In this area the prevalence ratio was 101/ 100,000 and the age-adjusted mean annual incidence 4.1/100,000. Of 51 probands, 29% had a second case of MS in their family. In the 51 sibships, 236 sibs were alive and 8% of them were familial cases of MS. The recurrence risk of MS for sibs was 2.5%. This means that MS occurs 25 times more often among sibs of MS patients than in the general population of the same geographic area. Of living sibs, 60% were still at risk for subsequent MS.
ISSN:0251-5350
DOI:10.1159/000110844
出版商:S. Karger AG
年代:1984
数据来源: Karger
|
4. |
Tracers for Paralysis Agitans in Epidemiological Research |
|
Neuroepidemiology,
Volume 3,
Issue 2-3,
1984,
Page 82-96
Jesus de Pedro,
Urban Rosenqvist,
Preview
|
PDF (1398KB)
|
|
摘要:
If patients with parkinsonism were the only users of antiparkinsonian drugs and the drugs were utilized by the majority of the patients, the prevalence of the disease could be estimated from information on drug sales. The present study examines whether these prerequisites are fulfilled and whether the quality of the information on antiparkinsonian drug utilization in Sweden is sufficient for epidemiological use. Information on the use of antiparkinsonian drugs was collected from different registers of the Swedish National Corporation of Pharmacies. The quality of the data was good and made it possible to calculate the age-specific use of drugs by patients with parkinsonism. Levodopa derivatives (L-dopa + decarboxylase inhibitors) were found to be the best tracers for parkinsonism.
ISSN:0251-5350
DOI:10.1159/000110845
出版商:S. Karger AG
年代:1984
数据来源: Karger
|
5. |
Tracers for Paralysis Agitans in Epidemiological Research |
|
Neuroepidemiology,
Volume 3,
Issue 2-3,
1984,
Page 97-107
Jesus de Pedro,
Urban Rosenqvist,
Preview
|
PDF (1069KB)
|
|
摘要:
A mathematical model has been constructed to estimate the prevalence of parkinsonism from register information on the use of a tracer drug in a defined geographical area. The prevalence of parkinsonism was estimated for several European countries using data on rates of L-dopa derivatives in 1980. The estimates were compared with data from community-based surveys of parkinsonism. The precision of the estimates as calculated by the coefficient of variation ranged between 1.6 and 6.9% and the accuracy as measured by the standard deviation of the percent error was 9.1 %. Up-to-date community-based data are not available. Using this calibrated model, the prevalence of parkinsonism in Sweden was estimated as 167.9/100,000.
ISSN:0251-5350
DOI:10.1159/000110846
出版商:S. Karger AG
年代:1984
数据来源: Karger
|
6. |
Long-Term Prognosis after Transient Ischaemic Attacks; pp. 108–122 |
|
Neuroepidemiology,
Volume 3,
Issue 2-3,
1984,
Page 108-122
S. Haberman,
Preview
|
PDF (1248KB)
|
|
摘要:
The published data of 34 studies of the long-term prognosis after transient ischaemic attacks (TIA) have been analysed. Despite the different types of investigation, the results, once the initial period of follow-up has been discounted, are consistent. The results indicate that, from approximately 1 year after onset of TIAs, the hazard rate is approximately constant and the level of excess annual mortality relative to general population experience is approximately 85%. At present, the data available to distinguish which is the superior between these two alternative descriptions of the long-term experience following TIA are not available.
ISSN:0251-5350
DOI:10.1159/000110847
出版商:S. Karger AG
年代:1984
数据来源: Karger
|
7. |
Long-Term Prognosis after Transient Ischaemic Attacks; pp. 123–128 |
|
Neuroepidemiology,
Volume 3,
Issue 2-3,
1984,
Page 123-128
S. Haberman,
Preview
|
PDF (673KB)
|
|
摘要:
The published data of 34 studies of the long-term prognosis after transient ischaemic attacks (TIA) have been analysed. Despite the different types of investigation, the results, once the initial period of follow-up has been discounted, are consistent. The results indicate that, from approximately 1 year after onset of TIAs, the hazard rate is approximately constant and the level of excess annual mortality relative to general population experience is approximately 85%. At present, the data available to distinguish which is the superior between these two alternative descriptions of the long-term experience following TIA are not available.
ISSN:0251-5350
DOI:10.1159/000110848
出版商:S. Karger AG
年代:1984
数据来源: Karger
|
8. |
Clinical Statistics in 515 Fatal Cases of Motor Neuron Disease |
|
Neuroepidemiology,
Volume 3,
Issue 2-3,
1984,
Page 129-138
Kiyotaro Kondo,
Isao Hemmi,
Preview
|
PDF (1006KB)
|
|
摘要:
In 515 cases of motor neuron disease followed until death, (1) the proportion of three subtypes of motor neuron disease (MND): amyotrophic lateral sclerosis (ALS), progressive bulbar paralysis (PBP), spinal progressive muscular atrophies (SPMA) was 78.3, 1.9, 19.8; (2) sex ratios were 1.41 in ALS, nearly one in PBP and 1.59 in SPMA, the ratio being high in cases initially involving the upper limbs; (3) age at onset was smoothly unimodal and identical in three subtypes; (4) bulbar symptoms appeared either at the initial stage or towards the fatal end; (5) duration was compatible with a compound Weibull distribution; (6) survival rates showed a reverted J type distribution and was more favorable in SPMA than ALS; (7) life expectancies decreased first but increased about 46 months after onset; (8) multivariate analysis disclosed that duration is shorter in ALS when age at onset was older, and when bulbar muscles or left limbs were initially affected, and in SPMA when age at onset was older, dysphagia was present, and probably in those patients who had a history of trauma.
ISSN:0251-5350
DOI:10.1159/000110849
出版商:S. Karger AG
年代:1984
数据来源: Karger
|
9. |
Clinical Statistics in 515 Fatal Cases of Motor Neuron Disease |
|
Neuroepidemiology,
Volume 3,
Issue 2-3,
1984,
Page 139-148
Kiyotaro Kondo,
Isao Hemmi,
Preview
|
PDF (938KB)
|
|
摘要:
In 515 cases of motor neuron disease followed until death, (1) the proportion of three subtypes of motor neuron disease (MND): amyotrophic lateral sclerosis (ALS), progressive bulbar paralysis (PBP), spinal progressive muscular atrophies (SPMA) was 78.3, 1.9, 19.8; (2) sex ratios were 1.41 in ALS, nearly one in PBP and 1.59 in SPMA, the ratio being high in cases initially involving the upper limbs; (3) age at onset was smoothly unimodal and identical in three subtypes; (4) bulbar symptoms appeared either at the initial stage or towards the fatal end; (5) duration was compatible with a compound Weibull distribution; (6) survival rates showed a reverted J type distribution and was more favorable in SPMA than ALS; (7) life expectancies decreased first but increased about 46 months after onset; (8) multivariate analysis disclosed that duration is shorter in ALS when age at onset was older, and when bulbar muscles or left limbs were initially affected, and in SPMA when age at onset was older, dysphagia was present, and probably in those patients who had a history of trauma.
ISSN:0251-5350
DOI:10.1159/000110850
出版商:S. Karger AG
年代:1984
数据来源: Karger
|
10. |
Mortality Data for the US for Deaths Due to and Related to Twenty Neurologic Diseases |
|
Neuroepidemiology,
Volume 3,
Issue 2-3,
1984,
Page 149-158
Vijay Chandra,
Nadir E. Bharucha,
Bruce S. Schoenberg,
Preview
|
PDF (777KB)
|
|
摘要:
Mortality data for the entire US for 20 categories of neurologic disease for the years 1971 and 1973–1978 were reviewed. Data were analyzed separately for deaths due to each disease (i.e., with the disease listed as the underlying cause of death) and for deaths related to the disease (i.e., with the disease listed as the underlying, immediate, associated, or contributory cause of death). Average annual age-, race-, and sex-specific mortality rates for deaths due to and deaths related to each of 20 neurologic disorders were calculated using as the denominator population estimates by age, race, and sex for the same years, obtained from a linear interpolation of the 1970 and 1980 US census data. Average annual age-adjusted mortality rates by race and sex were also calculated. The percent distribution of the registered underlying cause of death in people dying with each of the 20 categories of neurologic disease was also determined. Examination of these data emphasizes the importance of checking all deaths related to a disease to obtain more complete information about the disease from mortality dat
ISSN:0251-5350
DOI:10.1159/000110851
出版商:S. Karger AG
年代:1984
数据来源: Karger
|
|